EMIS Group PLC Acquisition Timetable Update (8082E)

TIDMEMIS TIDM0R0O

RNS Number : 8082E

EMIS Group PLC

01 November 2022

1 November 2022

EMIS Group plc

("EMIS" or "the Group")

Acquisition Timetable Update

Acquisition Timetable Update

On 17 June 2022, the Boards of Bidco and EMIS announced that they had reached agreement on the terms of a recommended all cash offer pursuant to which Bidco, an affiliate of Optum UK and a wholly-owned subsidiary of UnitedHealth Group, will acquire the entire issued and to be issued ordinary share capital of EMIS (the "Acquisition"). The Acquisition is being implemented by means of a Court-sanctioned scheme of arrangement under Part 26 of the Companies Act 2006 (the "Scheme").

On 9 August 2022, EMIS announced that at the Court Meeting to consider the Scheme and the General Meeting to consider the Special Resolution relating to the Acquisition, all resolutions were approved by the requisite majorities. EMIS further announced that a notification had been made and accepted under the NS&I Act and that the Secretary of State had confirmed that no further action will be taken in relation to the Acquisition.

As regards the remaining substantive regulatory condition to the Acquisition, Bidco and EMIS are in the process of finalising a Merger Notice with the Competition and Markets Authority ("CMA"), preliminary to a Phase One investigation of the Acquisition. As a result, unless the relevant condition is waived by Bidco, EMIS now expects the Scheme to become Effective in the first quarter of 2023.

Unless otherwise defined, all capitalised terms in this announcement shall have the same meaning given to them in the Scheme Document.

For further information, contact:

EMIS Group plc Tel: [phone]

Andy Thorburn, CEO

Peter Southby, CFO

www.emisgroupplc.com

@EMISGroup

   Numis Securities Limited (Nominated Adviser & Broker)           Tel: [phone] 

Joshua Hughes/Simon Willis/James Black

MHP Communications Tel: [phone]

   Reg Hoare/ Ollie Hoare/ Matthew Taylor/Pauline Guenot                    [e-mail] 

Information for investors can be found on the Group's website at www.emisgroupplc.com/investors .

Notes to Editors

EMIS Group has grown to become a UK leader in connected healthcare software and systems. Its solutions are widely used across a number of major UK healthcare settings. EMIS Group's aim is to join up healthcare through innovative technology, helping to deliver better health outcomes to the UK population, supporting longer and healthier lives.

EMIS Group has two core business segments: EMIS Health and EMIS Enterprise.

EMIS Health is a supplier of innovative integrated care technology to the NHS, including primary, community, acute and social care.

EMIS Enterprise is focussed on growth in the business-to-business technology sector within the healthcare market, including management of medicines, partner businesses, patient-facing services, data and analytics, and research and life sciences.

LEI: 213800K474ZZK76NX913

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [e-mail] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

OUPBKDBQOBDDOKN

(END) Dow Jones Newswires

November 01, 2022 03:00 ET (07:00 GMT)